lonsurf
les laboratoires servier - trifluridine, tipiracil hydrochloride - colorektale neoplasmer - antineoplastiske midler - colorectal cancerlonsurf is indicated in combination with bevacizumab for the treatment of adult patients with metastatic colorectal cancer (crc) who have received two prior anticancer treatment regimens including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and/or anti-egfr agents. lonsurf is indicated as monotherapy for the treatment of adult patients with metastatic colorectal cancer (crc) who have been previously treated with, or are not considered candidates for, available therapies including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and anti egfr agentsgastric cancerlonsurf is indicated as monotherapy for the treatment of adult patients with metastatic gastric cancer including adenocarcinoma of the gastroesophageal junction, who have been previously treated with at least two prior systemic treatment regimens for advanced disease.
bactrim 40 mg/ ml / 8 mg/ ml
eumedica pharmaceuticals gmbh - sulfametoksazol / trimetoprim - mikstur, suspensjon - 40 mg/ ml / 8 mg/ ml
bactrim 400 mg / 80 mg
eumedica pharmaceuticals gmbh - sulfametoksazol / trimetoprim - tablett - 400 mg / 80 mg
tribrissen vet 400 mg/ ml / 80 mg/ ml
intervet international bv - 5831 an - sulfadiazin / trimetoprim - injeksjonsvæske, suspensjon - 400 mg/ ml / 80 mg/ ml
canesten 10 mg/ g / 500 mg
bayer ab - solna - klotrimazol - krem, vaginaltablett - 10 mg/ g / 500 mg
canesten 10 mg/ g
bayer ab - solna - klotrimazol - krem - 10 mg/ g
canesten 500 mg / 10 mg/ g
bayer ab - solna - klotrimazol - krem, vaginalkapsel, myk - 500 mg / 10 mg/ g
canesten 10 mg/ g / 100 mg
bayer ab - solna - klotrimazol - krem, vaginaltablett - 10 mg/ g / 100 mg
canesten 100 mg
bayer ab - solna - klotrimazol - vaginaltablett - 100 mg